Laddar...
100-fold but not 50-fold dystrophin overexpression aggravates electrocardiographic defects in the mdx model of Duchenne muscular dystrophy
Dystrophin gene replacement holds the promise of treating Duchenne muscular dystrophy. Supraphysiological expression is a concern for all gene therapy studies. In the case of Duchenne muscular dystrophy, Chamberlain and colleagues found that 50-fold overexpression did not cause deleterious side effe...
Sparad:
| I publikationen: | Mol Ther Methods Clin Dev |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Nature Publishing Group
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4934459/ https://ncbi.nlm.nih.gov/pubmed/27419194 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mtm.2016.45 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|